Nanomedicine Meaning
Video shows what nanomedicine means. The use of nanotechnology for diagnosing, treating and preventing disease.. Any medicine containing nanoparticles.. Nanomedicine Meaning. How to ...
By: ADictionary
Visit link:
Nanomedicine Meaning - Video
Cancer itself is a very broad based topic. There are various forms of cancer and many different types of diagnostics and treatments that are currently available. In our earlier articles, we have touched on various aspects of cancer:
- Key facts with statistics - Major causes- The correlation between employment and the illness- Risk reduction- Types of treatment available- Treatment cost overview- Integrative and Preventive Medicine
So far, the treatment model that is proven by several sources to have the best results is through Integrative Medicine. Its approach is to combine conventional methods with both complementary and alternative therapies. It is very patient-centred, making use of natural products, modification of lifestyle, diet, a mind-body-spirit healing journey together with conventional treatments like chemotherapy.
Dr. ChatChai Sribundit (M.D) from Akesis Life Bangkok (akesisoncology.com) emphasises the important role that integrative medicine plays in todays cancer management and in many cancer-care programs. As he mentioned in earlier articles, almost one third of cancer cases are actually preventable. Risk factors can be eliminated and implementing existing evidence-based preventive strategies are definitely the winning formula.
In the long run, preventive strategies in the form of regular exercise and maintaining a healthy weight reduces the risk not only of cancer but many other primary medical conditions. In addition, a well-balanced lifestyle and healthy food provide both long and short term benefits. Apart from the above, Dr. Chatchai stands firmly by his 5 pillars consisting of medical intervention, diet & nutrition, physical therapy & exercise, emotional wellness and patient education.
Together with the basis of the 5 Pillars, early detection with timely and proper patient management can greatly reduce cancer risk. Many cancers have a high chance of cure if diagnosed early and treated adequately.
Chemotherapy and radiotherapy remain a mainstream form of treatment whereas tissue biopsy and scans are general diagnostic tools commonly used in Conventional therapies for cancer. In some cases, a targeted approach is lacking and patients can be vulnerable to certain types of drugs. Recently, new treatments have been emerging to improve the traditional options in cancer treatment with poor prognosis. Areas like nanomedicine and extracellular vesicles along with advances in immunotherapy and nanotechnology are becoming a norm for the next generation of cancer diagnosis and treatments.
Liquid Biopsy
Molecular targeting of specific oncogenic mutations in human cancer is now key for anti-cancer drug therapy as mutations lead to drug resistance. Therefore, the ability to detect and continuously monitor oncogenic mutations is important as it guides the use of targeted molecular therapies to improve long-term clinical outcomes in patients. Apart from direct sampling of cancer tissue by biopsy, oncogenic mutations are also detectable in circulating bodily fluids of patients which is a less invasive method.
Cancer biomarker discovery using DNA aptamersBiomarkers are molecules able to indicate specific physiological states of cells. Identifying reliable biomarkers is essential for early diagnosis and adaptive treatment strategies. According to pub.vsc.org, aptamers are single-stranded oligonucleotides generated by an in vitro screening method called Systematic Evolution of Ligands by Exponential Enrichment (SELEX). They can recognise their cognate targets with selectivity and affinity comparable to protein antibodies in cancer patients.
Nanomedicine
Treating cancer with nanotechnology has become one of the emerging trends. Studies reveal that treating cancer by nanoparticle enhances the efficiency of the treatment and also minimises adverse effects. The property of nanoparticles in treating cancer is target specific. Nanoparticles also target uncontrolled cell proliferation.
Extracellular vesicles (EVs) are released by all cells within the tumour microenvironment, such as endothelial cells, tumour-associated fibroblasts, pericytes, and immune system cells. The EVs carry the load of parental cells formed of proteins and nucleic acids, that convey cell-to-cell communication and also suppress tumour progression. Due to longevity of vesicles within the circulation and their ability to cross bloodbrain barriers, modification of these unique organelles offers the potential to create new biological-tools for cancer therapy.
These treatments help ones immune system to find and attack cancer cells the same way it attacks bacteria and viruses. It uses substances made by the body or in a laboratory to improve or restore immune system function. Immunotherapy may work by maximising the immune system to prevent or slow down the growth of cancer and reduce the probability of spreading. Some examples of immunotherapy, include, NK Cell therapy, Cancer vaccines (prophylactic or therapeutic) and T-cell therapy.
Commonly use in Integrative medicine and in conjunction with radiation, hyperthermia is a non-invasive method of increasing tumour temperature to stimulate blood flow and improve oxygenation. This makes cancer cells more sensitive during radiation therapy. Hyperthermia helps address the limitations of radiation for many patients by effectively increasing the radiation dose without increasing in unwanted side effects. There are significant results which show the effect of hyperthermia approach in treating cancer.
Longdom.org states that this treatment uses a drug called photosensitizer or photosensitizing agents. Agents and particular type of light are exposed at a specific wavelength. The specificity of wavelength depends on the production of oxygen. Oxygen destroys nearby Cancer cells. The wave length determines the distance travelled by the light into the body. The photosensitizer present in a tumour absorbs the light and produces oxygen which destroys surrounding cancer cells.
This treatment uses light amplification by the stimulated emission of radiation. Laser therapy for treating cancer includes special light beams instead of instruments. Laser therapy is normally given through an endoscopic tube. There are different types of laser therapies used for treatment of cancer. The Endoscope is inserted in the body to treat cancer or precancerous growth. Lasers can also be used to shrink or destroy tumours or precancerous growth.
The initial stage, which is most important, is the detection of cancer. Early detection could increase the possibility of cure and increases survival rates. However, poor prognosis due to lack of proper diagnosing methods and ineffective chemotherapeutic treatment is a common hurdle. As synthetic drugs cause many side effects, and cancer cells become resistant, more innovative treatment methods must be considered to give new hope for existing sufferers.
Author: Ezree Ebrahim, Business Development Consultant (Healthcare), Akesis Life by Absolute Health. For Further information, please contact: ezree.ebrahim@akesisoncology.com
Series Editor: Christopher F. Bruton, Executive Director, Dataconsult Ltd, chris@dataconsult.co.th. Dataconsults Thailand Regional Forum provides seminars and extensive documentation to update business on future trends in Thailand and in the Mekong Region.
More here:
Cancer in the workplace: Innovative diagnostic devices and treatments - Bangkok Post
Healthcare Nanotechnology (Nanomedicine) Market Report Delivering Growth Analysis with Key Trends of Top Companies (2020-2026)
A comprehensive research study on the Healthcare Nanotechnology (Nanomedicine) Marketwas recently published by Market Report Expert. This is an up-to-date report, covering the current COVID-19 impact on the market. The Coronavirus (COVID-19) has affected every aspect of life globally and thus altering the global market scenario. The changes in the market conditions are drastic. The swiftly changing market scenario and initial and future assessment of the impact on Healthcare Nanotechnology (Nanomedicine) market is covered in the report.The Healthcare Nanotechnology (Nanomedicine) Market report is a precise and deep-dive study on the current state that aims at the major drivers, market strategies, and imposing growth of the key players. Worldwide Healthcare Nanotechnology (Nanomedicine) Industry also offers a granular study of the dynamics, segmentation, revenue, share forecasts, and allows you to make superior business decisions. The report serves imperative statistics on the market stature of the prominent manufacturers and is an important source of guidance and advice for companies and individuals involved in the Healthcare Nanotechnology (Nanomedicine) industry.
The Global Healthcare Nanotechnology (Nanomedicine) Market poised to grow from US$ XX million in 2020 to US$ XX million by 2026 at a compound annual growth rate (CAGR) of XX% during the projection period of 2020-2026.
An Outline of the Major Key Players covered in this Report:
Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck& Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson& Johnson, Smith&Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International
Get Free LatestPDF Template of this Report(Including Covid-19 impact analysis on overall industry Forecast, Size, Share, CAGR and more.)@ https://www.marketreportexpert.com/report/_Healthcare_Nanotechnology_(Nanomedicine)_/14305/sample
Note: We can also provide market report in German/French Language.
The report puts together a succinct analysis of the growth drivers influencing the current business scenario across various regions and countries. Substantial information pertaining to the industry analysis size, share, application, and statistics are summed in the report in order to present a collaborative prediction. Additionally, this report encompasses a precise competitive analysis of major market players, innovative companies, and their strategies during the projection timeline.
The latest report on the Healthcare Nanotechnology (Nanomedicine) Market consists of an analysis of this industry and its type, application, and other segments. As per the report, the market is estimated to gain significant returns and register substantial y-o-y growth during the forecast period of 2020-2026.
Majortype, primarily split into
NanomedicineNano Medical DevicesNano DiagnosisOther
Major applications/end users, including
AnticancerCNS ProductAnti-infectiveOther
According to the report, the study offers details regarding the valuable estimations of the market such as market size, sales capacity, and profit projections. The report documents factors such as drivers, restraints, and opportunities that impacts the remuneration of this market.
Feel Free! Ask Our Industry Expert For Discount on this Report(Note: Our reports include the analysis of the impact of COVID-19 on this industry. Our updated sample pages shows impact of Covid-19 on Industry trends. Also we are offering 20% discount.): https://www.marketreportexpert.com/report/_Healthcare_Nanotechnology_(Nanomedicine)_/14305/inquiry
The research offers an analysis of the geographical landscape of the Healthcare Nanotechnology (Nanomedicine) Market, which is divided into regions such as North America, Europe, Asia Pacific, South America, and the Middle East & Africa. The segment includes data about several parameters related to the regional contribution such as market share, application share, type share, key companies in respective regions, market share of key companies in regional market, growth rate and revenue of the regional market, sales, production, and consumption of the respective Healthcare Nanotechnology (Nanomedicine) market.
Major Highlights of TOC Covers:
Healthcare Nanotechnology (Nanomedicine) Market 2020, Healthcare Nanotechnology (Nanomedicine) Market size, Healthcare Nanotechnology (Nanomedicine) Market share, Healthcare Nanotechnology (Nanomedicine) Market analysis, Healthcare Nanotechnology (Nanomedicine) Market forecast, Healthcare Nanotechnology (Nanomedicine) Market trends, Healthcare Nanotechnology (Nanomedicine) Market Research report, Healthcare Nanotechnology (Nanomedicine) application, Healthcare Nanotechnology (Nanomedicine) Trends, Healthcare Nanotechnology (Nanomedicine) Market growing CAGR, Healthcare Nanotechnology (Nanomedicine) Market Competitive Landscape, Healthcare Nanotechnology (Nanomedicine) Market Growth
Information related to the growth rate, revenue, sales, production, consumption, during the forecast period is included in the report. The Healthcare Nanotechnology (Nanomedicine) Market report claims that the industry is projected to generate significant revenue and sales during the forecast period. The report consists of information related to the market dynamics such as challenges involved in this vertical, growth opportunities, and driving factors affecting the market.
About Us
Market Report Expert is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports.
Contact USJames ThompsonMarket Report ExpertPhone: +1-816-301-6258Email inquiry@marketreportexpert.comWeb:-https://www.marketreportexpert.com
VANCOUVER, BC, Oct. 23, 2020 /CNW/ -Precision NanoSystems Inc. (PNI), a global leader in technologies and solutions in genetic medicine, announced today that it has received a commitment of up to $18.2 million in support from the Government of Canada under the Innovation, Science and Economic Development's (ISED) Strategic Innovation Fund (SIF) to develop a COVID-19 vaccine. PNI will use the investment to advance a best-in-class COVID-19 mRNA vaccine candidate to clinical trials.
PNI provides over 250 industry and academic partners with solutions for the development of vaccines, gene therapies, and cell therapies, in the areas of infectious diseases, oncology and rare diseases. With this investment from the Government of Canada, PNI's Chief Scientific Officer, Dr. Andrew Geall, and his team will use their state-of-the-art technology platforms and expertise in self-amplifying mRNA vectors, lipid-based drug delivery systems and nanomedicine manufacturing to develop a cost-effective COVID-19 vaccine.
As part of Canada's efforts to combat COVID-19, the Strategic Innovation Fund is working diligently to support projects led by the private sector for COVID-19 related vaccine and therapy clinical trials to advance Canada's medical countermeasures in the fight against COVID-19. "An effective vaccine will be critical as we work to contain the COVID-19 virus and prevent future infections.Today's contribution will support PNI to advance the development of a mRNA vaccine candidate through pre-clinical studies and clinical trials to help protect Canadians," stated the Honourable Navdeep Bains, Minister of Innovation, Science and Industry.
Bringing together its proprietary technology platforms, key partnerships and unparalleled expertise in nanomedicines, PNI is excited to be leading the development of a Made-in-Canada COVID vaccine. James Taylor, CEO and co-founder of PNI said "Since its inception PNI has executed on its mission to accelerate the creation of transformative medicines. It is an honour to be supported by the Canadian government in this global fight against COVID-19 and to further build capabilities for rapid response against COVID-19 and future pandemics"
About Precision NanoSystems Inc. (PNI)
PNI is a global leader in ushering in the next wave of genetic medicines in infectious diseases, cancer and rare diseases. We work with the world's leading drug developers to understand disease and create the therapeutics and vaccines that will define the future of medicine.PNI offers proprietary technology platforms and comprehensive expertise to enable researchers to translate disease biology insights into non-viral genetic medicines.
SOURCE Precision Nanosystems
Read more from the original source:
Precision NanoSystems Receives $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19 - BioSpace
Nanomedicine Market
UpMarketResearch, 29-07-2020: The research report on the Nanomedicine Market is a deep analysis of the market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. Experts have studied the historical data and compared it with the changing market situations. The report covers all the necessary information required by new entrants as well as the existing players to gain deeper insight.
Furthermore, the statistical survey in the report focuses on product specifications, costs, production capacities, marketing channels, and market players. Upstream raw materials, downstream demand analysis, and a list of end-user industries have been studied systematically, along with the suppliers in this market. The product flow and distribution channel have also been presented in this research report.
Get a PDF Copy of the Sample Report for Free @ https://www.upmarketresearch.com/home/requested_sample/11972
The Major Manufacturers Covered in this Report:CombimatrixAblynxAbraxis BioscienceCelgeneMallinckrodtArrowhead ResearchGE HealthcareMerckPfizerNanosphereEpeius BiotechnologiesCytimmune SciencesNanospectra Biosciences
The Research Study Focuses on:
By Types:Quantum dotsNanoparticlesNanoshellsNanotubesNanodevices
By Applications:Segmentation encompasses oncologyInfectious diseasesCardiologyOrthopedicsOthers
By Regions:
To get this report at incredible Discounts, visit @ https://www.upmarketresearch.com/home/request_for_discount/11972
The Nanomedicine Market Report Consists of the Following Points:
Make an Inquiry of the Nanomedicine Market Report @ https://www.upmarketresearch.com/home/enquiry_before_buying/11972
In conclusion, the Nanomedicine Market report is a reliable source for accessing the research data that is projected to exponentially accelerate your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rate, and figures. SWOT analysis is also incorporated in the report along with speculation attainability investigation and venture return investigation.
About UpMarketResearch:Up Market Research (https://www.upmarketresearch.com) is a leading distributor of market research report with more than 800+ global clients. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.
Contact Info UpMarketResearchName Alex MathewsEmail [emailprotected]Organization UpMarketResearchAddress 500 East E Street, Ontario, CA 91764, United States.
See original here:
Nanomedicine Market Report (2019-2027) | The demand for the Market will drastically increase in the Future? - Research Newspaper
Note: Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Radiocontrast AgentMarket which would mention How the Covid-19 is Affecting the Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Key Regions and Proposal for Radiocontrast Agent Market Players to battle Covid-19 Impact.
The Radiocontrast AgentMarket report is compilation of intelligent, broad research studies that will help players and stakeholders to make informed business decisions in future. It offers detailed research and analysis of key aspects of the Radiocontrast Agent market. Readers will be able to gain deeper understanding of the competitive landscape and its future scenarios, crucial dynamics, and leading segments of the global Radiocontrast Agent market. Buyers of the report will have access to accurate PESTLE, SWOT and other types of analysis on the global Radiocontrast Agent market. Moreover, it offers highly accurate estimations on the CAGR, market share, and market size of key regions and countries. Players can use this study to explore untapped Radiocontrast Agent markets to extend their reach and create sales opportunities.
The study encompasses profiles of major Companies/Manufacturers operating in the global Radiocontrast Agent Market.Key players profiled in the report include:GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India) and More
Get PDF Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, List of Tables & Figures, Chart):https://www.marketinforeports.com/Market-Reports/Request-Sample/161165
Segmental Analysis:The report has classified the global Radiocontrast Agent market into segments including product type and application. Every segment is evaluated based on share and growth rate. Besides, the analysts have studied the potential regions that may prove rewarding for the Radiocontrast Agent manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, there by helping market players to gain deep insights into the overall Radiocontrast Agent industry.
Market Segment By Type:Barium-based Radiocontrast AgentIodinated Radiocontrast AgentGadolinium-based Radiocontrast AgentMicrobubble Radiocontrast AgentX-ray/Computed Tomography (CT)Magnetic Resonance Imaging (MRI)UltrasoundMarket Segment By Application:RadiologyInterventional RadiologyInterventional Cardiology
To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketinforeports.com/Market-Reports/Request_discount/161165
The authors of the report have analyzed both developing and developed regions considered for the research and analysis of the global Radiocontrast Agent market. The regional analysis section of the report provides an extensive research study on different regional and country-wise Radiocontrast Agent industry to help players plan effective expansion strategies.
Regions Covered in the Global Radiocontrast Agent Market: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
Years Considered to Estimate the Market Size:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year: 2020-2025
For More Information:https://www.marketinforeports.com/Market-Reports/161165/Radiocontrast-Agent-market
Customization of the Report:Market Info Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.
Get Customization of the [emailprotected]:https://www.marketinforeports.com/Market-Reports/Request-Customization/161165/Radiocontrast-Agent-market
Get in Touch with Us :Mr. Marcus KelCall: +1 915 229 3004 (U.S)+44 7452 242832 (U.K)Email: [emailprotected]Website: http://www.marketinforeports.com
See original here:
Impact of COVID-19 on Radiocontrast Agent Market Global Industry Outlook, Share, Growth Analysis, Trends and top manufacture like GE Healthcare (US),...
Scientists in the cancer nanomedicine community debate whether use of nanoparticles can best deliver drug therapy to tumors passively, allowing the nanoparticles to diffuse into tumors and become held in place, or actively, adding a targeted anti-cancer molecule to bind to specific cancer cell receptors and, in theory, keep the nanoparticle in the tumor longer. Now, new research on human and mouse tumors in mice by investigators at the Johns Hopkins Kimmel Cancer Center suggests the question is even more complicated.
Laboratory studies testing both methods in six models of breast cancer; five human cancer cell lines and one mouse cancer in mice with three variants of the immune system found that nanoparticles coated with trastuzumab, a drug that targets human epidermal growth factor receptor 2 (HER2)-positive breast cancer cells, were better retained in the tumors than plain nanoparticles, even in tumors that did not express the pro-growth HER2 protein. However, immune cells of the host exposed to nanoparticles induced an anti-cancer immune response by activating T cells that invaded and slowed tumor growth. The results of the work Nanoparticle interactions with immune cells dominate tumor retention and induce T cellmediated tumor suppression in models of breast cancer, appears in Science Advances.
The factors that influence nanoparticle fate in vivo following systemic delivery remain an area of intense interest. Of particular interest is whether labeling with a cancer-specific antibody ligand (active targeting) is superior to its unlabeled counterpart (passive targeting). Using models of breast cancer in three immune variants of mice, we demonstrate that intratumor retention of antibody-labeled nanoparticles was determined by tumor-associated dendritic cells, neutrophils, monocytes, and macrophages and not by antibody-antigen interactions, write the investigators.
Systemic exposure to either nanoparticle type induced an immune response leading to CD8+ T cell infiltration and tumor growth delay that was independent of antibody therapeutic activity. These results suggest that antitumor immune responses can be induced by systemic exposure to nanoparticles without requiring a therapeutic payload. We conclude that immune status of the host and microenvironment of solid tumors are critical variables for studies in cancer nanomedicine and that nanoparticle technology may harbor potential for cancer immunotherapy.
Its been known for a long time that nanoparticles, when injected into the bloodstream, are picked up by scavenger-like macrophages and other immune system cells, explains senior study author Robert Ivkov, PhD, associate professor of radiation oncology and molecular radiation sciences at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Many researchers in the field have been focused on trying to reduce interactions with immune cells, because they have been trying to increase the circulation time of the nanoparticles and their retention in tumor cells. But our study demonstrates that the immune cells in the tumor collect and react to the particles in such a way to stimulate an anti-cancer response. This may hold potential for advancing beyond drug delivery toward developing cancer immunotherapies.
The investigators conducted a few in vitro experiments in their study. First, they applied some plain starch-coated iron oxide nanoparticles and others coated with trastuzumab to five human breast cancer cell lines, finding that the amount of binding between the trastuzumab-coated nanoparticles and cells depended on how much the cancer cells expressed the oncogene HER2. In people, HER2-positive breast cancers are among the most resistant to standard chemotherapy.
Trastuzumab, sold under the name Herceptin, targets the HER2-positive tumor cells and triggers the immune system as well.
Responses were surprisingly different in animal models, the researchers report. In separate experiments, the team used the nanoparticles in two immune-deficient strains of mice engrafted with cells from five human breast cancer cell linestwo that were HER2 negative and three that were HER2 positive. When they studied the animals tumors 24 hours later, they noticed that nanoparticles coated with trastuzumab were found in a concentration two to five times greater than the plain nanoparticles in all types of tumors, regardless of whether they expressed the HER2 protein. They also found that the number of trastuzumab-coated nanoparticles was even greater (tenfold) in mice that had a fully functional immune system and were bearing mouse-derived tumors.
This led the researchers to suspect that the host animals immune systems were interacting strongly with the nanoparticles and playing a role in determining retention of the particles in the tumor, whether or not a drug was added.
More experiments, the team reports, revealed that tumor-associated immune cells were responsible for collecting the nanoparticles, and that mice bred with an intact immune system retained more of the trastuzumab-coated nanoparticles than mice bred without a fully functioning immune system.
In addition, inflammatory immune cells in the tumors immediate surroundings, or microenvironment, seized more of the coated nanoparticles than the plain ones. Finally, in a series of 30-day experiments, the researchers found that exposure to nanoparticles inhibited tumor growth three to five times more than controls, and increased CD8-positive cancer-killing T cells in the tumors.
Surprisingly, Ivkov notes, the anti-cancer immune activating response was equally effective with exposure to either plain or trastuzumab-coated nanoparticles. Mice with defective T cells did not show tumor growth inhibition. The investigators say this demonstrated that systemic exposure to nanoparticles can cause a systemic host immune response that leads to anti-cancer immune stimulation and does not require nanoparticles to be inside the tumors.
Overall, our work suggests that complex interdependencies exist between the host and tumor immune responses to nanoparticle exposure, Ivkov says. These results offer intriguing possibilities for exploring nanoparticle targeting of the tumor immune microenvironment. They also demonstrate exciting new potential to develop nanoparticles as platforms for cancer immune therapies.
The investigators say they also plan to study whether the same types of immune responses can be generated for noncancer conditions, such as infectious diseases.
Continue reading here:
What Might be the Best Way to Delivery Nanoparticle Therapy for Cancer? - Genetic Engineering & Biotechnology News
The research report on the Nanomedicine Market offers a comprehensive study on market share, size, growth aspects, and major players. In addition, the report contains brief information about the regional competitive landscape, market trends, and drivers, opportunities and challenges, distributors, sales channels, risks & entry barriers, as well as Porters Five Forces Analysis. Moreover, the main objective of this report is to offer a detailed analysis of how the market aspects potentially influence the coming future of the Nanomedicine market. The report also offers a comprehensive analysis about the competitive manufacturers as well as the new entrants also studies along with their brief research.
The report includes the latest coverage of the impact of COVID-19 on the Nanomedicine industry. The incidence has affected nearly every aspect of the business domain. This study evaluates the current scenario and predicts future outcomes of the pandemic on the global economy.
Get | Download Sample Copy of Nanomedicine Market Research Report @ https://www.marketresearchintellect.com/download-sample/?rid=201321&utm_source=NYH&utm_medium=888
In addition, this report also contains a price, revenue, market share, and production of the service providers is also mentioned with accurate data. Moreover, the global Nanomedicine report majorly focuses on the current developments, new possibilities, advancements, as well as dormant traps. Furthermore, the Nanomedicine market report offers a complete analysis of the current situation and the advancement possibilities of the Nanomedicine market across the globe. This report analyses substantial key components such as production, capacity, revenue, price, gross margin, sales revenue, sales volume, growth rate, consumption, import, export, technological developments, supply, and future growth strategies.
We provide a detailed analysis of key players operating in the Nanomedicine Market:
Moreover, the Nanomedicine report offers a detailed analysis of the competitive landscape in terms of regions and the major service providers are also highlighted along with attributes of the market overview, business strategies, financials, developments pertaining as well as the product portfolio of the Nanomedicine market. Likewise, this report comprises significant data about market segmentation on the basis of type, application, and regional landscape. The Nanomedicine market report also provides a brief analysis of the market opportunities and challenges faced by the leading service provides. This report is specially designed to know accurate market insights and market status.
By Regions:
* North America (The US, Canada, and Mexico)
* Europe (Germany, France, the UK, and Rest of the World)
* Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
* Latin America (Brazil and Rest of Latin America.)
* Middle East & Africa (Saudi Arabia, the UAE, , South Africa, and Rest of Middle East & Africa)
To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=201321&utm_source=NYH&utm_medium=888
Table of Content
1 Introduction of Nanomedicine Market
1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions
2 Executive Summary
3 Research Methodology
3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources
4 Nanomedicine Market Outlook
4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis
5 Nanomedicine Market, By Deployment Model
5.1 Overview
6 Nanomedicine Market, By Solution
6.1 Overview
7 Nanomedicine Market, By Vertical
7.1 Overview
8 Nanomedicine Market, By Geography
8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East
9 Nanomedicine Market Competitive Landscape
9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies
10 Company Profiles
10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments
11 Appendix
11.1 Related Research
Get Complete Report
@ https://www.marketresearchintellect.com/need-customization/?rid=201321&utm_source=NYH&utm_medium=888
About Us:
Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.
Contact Us:
Mr. Steven Fernandes
Market Research Intellect
New Jersey ( USA )
Tel: +1-650-781-4080
Tags: Nanomedicine Market Size, Nanomedicine Market Trends, Nanomedicine Market Growth, Nanomedicine Market Forecast, Nanomedicine Market Analysis Sarkari result, Government Jobs, Sarkari naukri, NMK, Majhi Naukri,
Our Trending Reports
Double Piston Screen Changers Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026
Down-draught Gasifier Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026
Dozers Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026
See more here:
Nanomedicine Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 - Cole of Duty
Nanomedicine Market has witnessed continuous growth within the past few years and is projected to grow even more throughout the forecast period (2020 2027). The analysis presents a whole assessment of the market and contains Future trends, Current Growth Factors, attentive opinions, facts, historical information, and statistically supported and trade valid market information.
The report, titled Global Nanomedicine Market defines and briefs readers about its products, applications, and specifications. The research lists key companies operating in the global market and also highlights the key changing trends adopted by the companies to maintain their dominance. By using SWOT analysis and Porters five force analysis tools, the strengths, weaknesses, opportunities, and threats of key companies are all mentioned in the report. All leading players in this global market are profiled with details such as product types, business overview, sales, manufacturing base, competitors, applications, and specifications.
You Can Request A Demo Version of Report Before Buying (Higher Preference For Corporate Email ID User): https://www.worldwidemarketreports.com/sample/205987
GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., Sigma-Tau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd., UCB (Union chimique belge) S.A of the major organizations dominating the global market.(*Note: Other Players Can be Added per Request)
1. Industry outlookThis is where youll find the current state of the Nanomedicine industry overall and where its headed. Relevant industry metrics like size, trends, life cycle, and projected growth included here. This report comes prepared with the data to back up your business idea. On a regional basis, the Global Nanomedicine market has been segmented into Asia-Pacific, North America, Europe, Latin America, and the Middle East and Africa.
2. Target marketThis target market section of study includes the following:
User persona and characteristics: It includes demographics such as age, income, and location. It lets you know what their interests and buying habits are, as well as explain the best position to meet their needs.
Market size: How big is the potential Nanomedicine market for your business? It brings to light the consumption in the Nanomedicine industry by the type and application.
3. Competitive analysisDiscover your competitors. The report lets you know what youre up against, but it also lets you spot the competitions weaknesses. Are there customers that are underserved? What can you offer that similar businesses arent offering? The competitive analysis contains the following components:
Direct competitors: What other companies are offering similar products and services? Which companies are your true competitors?
Competitor strengths and weaknesses: What is your competition good at? Where do they fall behind? Get insights to spot opportunities to excel where others are falling short.
Barriers to entry: What are the potential pitfalls of entering the Nanomedicine market? Whats the cost of entry? Is it prohibitively high, or easy to enter?
The window of opportunity:Does your entry into the Nanomedicine industry rely on time-sensitive technology? Do you need to enter early to take advantage of an emerging market?
4. ProjectionsLikewise, We offered thoughtful, not hockey-stick forecasting.
Market share:We have given the consumption behavior of users. When you know how much can your future customers spend, then only youll understand how much of the Nanomedicine industry you have a chance to grab, and here we came up with real stats and numbers.
Impact Analysis of COVID-19:The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into account the political, economic, social, and technological parameters.
Finally, It is one report that hasnt shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of the Nanomedicine Industry, per application. Most noteworthy, this market analysis will help you find market blind spots.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends.
Contact Us:
Mr. ShahWorldwide Market ReportsSeattle, WA 98154,U.S.Email: [emailprotected]
February 6, 2017 (a) MMP-2 represented by little scissors is an enzyme that cleaves the extracellular matrix and allows cancer to metastasize to other tissues. (b) The MRI signal is turned "ON" when the linker between the two magnetic materials is cleaved by MMP-2. (c) MRI image of a mouse cancer model, showing strong MRI signals (orange color) appearing only in the cancerous region. Credit: IBS
A research team led by CHEON Jinwoo at the Center for Nanomedicine, within the Institute for Basic Science (IBS), developed the Nano MRI Lamp: A new technology platform that tunes the magnetic resonance imaging (MRI) signals "ON" only in the presence of the targeted disease. Published in Nature Materials, this study can overcome the limitations of existing MRI contrast agents.
MRI is an increasingly popular non-invasive technique for diagnosis and, importantly, does not use harmful radiation. Some tissues show a natural contrast on MRI, but for some specific types of imaging, patients are administered a MRI contrast agent to enhance the difference between the target area and the rest of the body. "Typical MRI contrast agents, like gadolinium, are injected in an "ON" state and distributed across the whole biological system with relatively large background signal," explains Director Cheon. "We found a new principle to switch the MRI contrast agent "ON" only in the location of the target." IBS scientists discovered how to switch the signal ON/OFF by using the Nano MRI Lamp.
The Nano MRI Lamp technology consists of two magnetic materials: A quencher (magnetic nanoparticle) and an enhancer (MRI contrast agent). The switch is due to the distance between the two. When the two materials are at a critical distance, farther than 7 nanometers (nm), the MRI signal is "ON", whereas when they are placed closer than 7 nm, the MRI signal is "OFF". The researchers named this phenomenon Magnetic REsonance Tuning (MRET), which is analogous to the powerful optical sensing technique called Fluorescence Resonance Energy Transfer (FRET).
The video will load shortly
The researchers tested the Nano MRI Lamp for cancer diagnosis. They detected the presence of an enzyme that can induce tumor metastasis, MMP-2 (matrix metalloproteinase-2) in mice with cancer. They connected the two magnetic materials with a linker that is naturally cleaved by MMP-2. Since the linker keeps the two materials close to each other, the MRI signal was "OFF". However, in the presence of the cancer, the linker is cleaved by MMP-2, which cause the two materials to be separated and the MRI signal switched "ON". Therefore, the MRI signal indicated the location of MMP-2, and the tumor. The scientists also found that the brightness of the MRI signal correlates with the concentration of MMP-2 in the cancerous tissue.
Most importantly, the Nano MRI Lamp remains switched off until it meets a biomarker associated with a specific disease, allowing higher sensitivity. "The current contrast agent is like using a flashlight during a sunny day: Its effect is limited. Instead, this new technology is like using a flash light at night and therefore more useful," explains Cheon.
Beyond cancer diagnosis, the Nano MRI Lamp can, in principle, be applied to investigate a variety of biological events, such as enzymolysis, pH variation, protein-protein interactions, etc. IBS scientists expect that it would be useful for both in vitro and in vivo diagnostics.
"Although we still have a long way to go, we established the principle and believe that the MRET and Nano MRI Lamp can serve as a novel sensing principle to augment the exploration of a wide range of biological systems," concludes Cheon. The research group is now working on developing safer and smarter multitasking contrast agents, which can simultaneously record and interpret multiple biological targets, and eventually allow a better understanding of biological processes and accurate diagnosis of diseases.
Explore further: Better contrast agents based on nanoparticles
More information: Distance-dependent magnetic resonance tuning as a versatile MRI sensing platform for biological targets, Nature Materials, nature.com/articles/doi:10.1038/nmat4846
Scientists at the University of Basel have developed nanoparticles which can serve as efficient contrast agents for magnetic resonance imaging. This new type of nanoparticles produce around ten times more contrast than the ...
(PhysOrg.com) -- Accurate visualization of living systems is key to the correct diagnosis and effective treatment of many diseases, as well as an improved understanding of biological processes. Magnetic resonance imaging ...
(Phys.org)A new type of nanoparticle-based MRI contrast agent demonstrates selectivity for tumor cells over non-cancerous cells, can detect hypoxia, and is sensitive enough allow for the detection of difficult-to-find ...
Ordinary sugar could become a contrast agent of the future for use in magnetic resonance tomography examinations of tumours. Malignant tumours show higher sugar consumption than surrounding tissue.
Nanoscale, inorganic fluorescent imaging agents such as quantum dots have become an important tool for researchers studying key biomolecules involved in cancer. At the same time, magnetic iron oxide nanoparticles are proving ...
Scientists from the Helmholtz Zentrum Mnchen and the Technische Universitt Mnchen have succeeded in a breakthrough for the further development of contrast agents and consequently improved diagnostics with imaging using ...
(Phys.org)In an effort to curb the adverse environmental impacts of paper production, researchers in a new study have developed a light-printable paperpaper that can be printed with UV light, erased by heating to 120 ...
Scientists used one of the world's most powerful electron microscopes to map the precise location and chemical type of 23,000 atoms in an extremely small particle made of iron and platinum.
Researchers at The University of Manchester have developed a method of producing water-based and inkjet printable 2-D material inks, which could bring 2-D crystal heterostructures from the lab into real-world products.
Rice University researchers have synthesized a new and greatly improved generation of contrast agents for tagging and real-time tracking of stem cells in the body.
Imaging very small materials takes not only great skill on the part of the microscopist, but also great instruments and techniques. For a refined microscopic look at biological materials, the challenges include getting an ...
Hold on, there, graphene. You might think you're the most interesting new nanomaterial of the century, but boron might already have you beat, according to scientists at Rice University.
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Go here to see the original:
Scientists devise a new platform to overcome the limits of MRI contrast agents - Phys.Org
The global Nanomedicine market study presents an all in all compilation of the historical, current and future outlook of the market as well as the factors responsible for such a growth. With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each Nanomedicine market player in a comprehensive way. Further, the Nanomedicine market report emphasizes the adoption pattern of the Nanomedicine across various industries.
The Nanomedicine market report examines the operating pattern of each player new product launches, partnerships, and acquisitions has been examined in detail.
Request Sample Report @https://www.mrrse.com/sample/3117?source=atm
market dynamics section of this report analyzes the impact of drivers and restraints on the global nanomedicine market. The impact of these drivers and restraints on the global nanomedicine market provides a view on the market growth during the course of the forecast period. Increasing research activities to improve the drug efficacy coupled with increasing government support are considered to be some of the major driving factors in this report. Moreover, few significant opportunities for the existing and new market players are detailed in this report.
Porters five forces analysis provides insights on the intensity of competition which can aid in decision making for investments in the global nanomedicine market. The market attractiveness section of this report provides a graphical representation for attractiveness of the nanomedicine market in four major regions North America, Europe, Asia-Pacific and Rest of the World, based on the market size, growth rate and industrial environment in respective regions, in 2012.
The global nanomedicine market is segmented on the basis of application and geography and the market size for each of these segments, in terms of USD billion, is provided in this report for the period 2011 2019. Market forecast for this applications and geographies is provided for the period 2013 2019, considering 2012 as the base year.
Based on the type of applications, the global nanomedicine market is segmented into neurological, cardiovascular, oncology, anti-inflammatory, anti-infective and other applications. Other applications include dental, hematology, orthopedic, kidney diseases, ophthalmology, and other therapeutic and diagnostic applications of nanomedicines. Nanoparticle based medications are available globally, which are aimed at providing higher bioavilability and hence improving the efficacy of drug. There have been increasing research activities in the nanomedicine filed for neurology, cardiovascular and oncology applications to overcome the barriers in efficient drug delivery to the target site. Moreover, the global nanomedicine market is also estimated and analyzed on the basis of geographic regions such as North America, Europe, Asia-Pacific and Rest of the World. This section describes the nanomedicine support activities and products in respective regions, thus determining the market dynamics in these regions.
The report also provides a few recommendations for the exisitng as well as new players to increase their market share in the global nanomedicine market. Some of the key players of this market include GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck & Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott Laboratories and others. The role of these market players in the global nanomedicine market is analyzed by profiling them on the basis of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.
The global nanomedicine market is categorized into the following segments:
Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/3117?source=atm
The Nanomedicine market report offers a plethora of insights which include:
The Nanomedicine market report answers important questions which include:
The Nanomedicine market report considers the following years to predict the market growth:
Buy This Report @ https://www.mrrse.com/checkout/3117?source=atm
Why Choose Nanomedicine Market Report?
Nanomedicine Market Reportfollows a multi- disciplinary approach to extract information about various industries. Our analysts perform thorough primary and secondary research to gather data associated with the market. With modern industrial and digitalization tools, we provide avant-garde business ideas to our clients. We address clients living in across parts of the world with our 24/7 service availability.
See original here:
Nanomedicine Market : Analysis and In-depth study on market Size Trends, Emerging Growth Factors and Forecasts to 2025 - Jewish Life News
44 - Nanomedicine by Toni Castro
44 - Nanomedicine by Toni Castro.
By: Bruce Rasmussen
Go here to see the original:
44 - Nanomedicine by Toni Castro - Video
Profiles in Nanomedicine Research: Kohut
By: ISUengineering
Read this article:
Profiles in Nanomedicine Research: Kohut - Video
Nanomedicine is the medical application of nanotechnology that will hopefully lead to useful research tools, advanced drug delivery systems, and new ways to treat disease or repair damaged tissues and cells. Drug delivery is currently the most advanced application of nanotechnology in medicine. Nanoscale particles are being developed to improve drug bioavailability, a major limitation in the design of new drugs. Poor bioavailability is especially problematic with newer and still experimental RNA interference therapy. Lipid or polymer-based nanoparticles are taken up by cells due to their small size, rather than being cleared from the body. These nanoparticles can be used to shuttle drugs into cells which may not have accepted the drug on its own. The nanoparticle chaperone may also be able to specifically target certain cell types, possibly reducing toxicity and improving efficacy. Nanoparticles such as quantum dot nanocrystals are the size of a protein molecule or short stretch of DNA. Quantum dots can be engineered to absorb and emit many wavelengths of light with very sharp precision. This makes them ideal for protein-protein interaction studies as they can be linked to molecules to form long-lived probes. They can track biological events by tagging specific proteins or DNA in order to follow their progress through biological pathways. In medicine, quantum dots could be used for diagnostic purposes. Dendrimers are another interesting and powerful use of nanotechnology in medicine. Dendrimers are nanostructured synthetic molecules with a regular branching structure projecting from a central core. Dendrimers form one layer at a time so the size of the dendrimer is determined by the number of synthetic steps. Each dendrimer is usually only a few nanometers wide. The outside layer can be engineered to be composed of specific functional groups that can act as hooks to specifically bind other molecules such as DNA. Dendrimers may act as effective agents for delivering DNA into cells during gene therapy. While viral vectors typically trigger an immune response, in principle, dendrimers should not. Nanorobotics or molecular nanotechnology involves the creation of complex mechanical systems constructed from the molecular level. Richard Feynman was the first to propose using machine tools to make smaller machine tools which can make smaller machine tools down to the atomic level. DNA makes an ideal material for the construction of nanomachines due to its stiffness. The intermolecular interactions of DNA are well-known and can be easily predicted. The self-assembly of DNA further facilitates its use as a construction material. Dr. Nadrian Seeman pioneered the use of DNA as a construction material and can make virtually any regular 3D shape. In 1999 his group succeeded in building the first nanoscale robotic actuator from DNA. DNA and later, nanotubes, have been used to construct molecular tweezers which can be used to physically manipulate nanostructures. Research into the construction of nanomotors has advanced greatly and nanomotors will form an important part of future nanorobots. Carlo Montemagno at Cornell has mutated the central rotating shaft of ATPase to have metal-binding amino acids that allow the ATPase to bind to nanoscale nickel pedestals. A silicon bar 100 nanometers long was bound to the rotor subunit of each ATPase by self-assembly, creating an ATP-powered molecular motor. These nanorobots may eventually form sophisticated cellular factories, used to synthesize drugs, repair damaged DNA, and releasing drugs on command.
More:
WEST HARTFORD, Conn., April 17, 2014 /PRNewswire-iReach/ --
Global Information Inc. announces the addition of a new market research report "Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019" at GIIResearch.com
This report includes market estimations for nanomedicine market for the forecast period 2013 - 2019. The market size is represented in terms of USD billion and the market estimates and forecasts are calculated, considering 2012 as the base year. Moreover, market trends and recent developments have been kept into account while forecasting market growth and revenue for the period 2013 - 2019.
The overall nanomedicine market is segmented on the basis of application and geography and the market estimations for each of these segments, in terms of USD billion, is provided in this report.
The nanomedicine market, by applications is segmented into neurological, cardiovascular, oncology, anti-inflammatory, anti-infective and other markets. The nanomedicine market is also estimated and analyzed on the basis of geographic regions such as North America, Europe, Asia-Pacific and rest of the world.
Table of Contents
Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Nanomedicine Market Overview Chapter 4 Global Nanomedicine Market, by Applications Chapter 5 Global Nanomedicine Market, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles List of Tables and Figures
More detailed information is available at http://www.giiresearch.com/report/tsm294638-nanomedicine-market-neurology-cardiovascular-anti.html
Media Contact: Joe Malley, Global Information, Inc., 860-674-8796, US-marketing@gii.co.jp
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
Read more:
NANOMEDICINE 3 Quantum Dot Technology for Multiplexing Applications#
By: NanoMedicine
Read the rest here:
NANOMEDICINE 3 Quantum Dot Technology for Multiplexing Applications# - Video
Regulatory News:
NANOBIOTIX (Euronext: NANO ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, today announced that it has been selected by the American Society of Clinical Oncology (ASCO) to present data from its clinical trial evaluating NBTXR3 in advanced soft tissue sarcoma.
The clinical trial will be presented during the congress session dedicated to sarcoma.
This years ASCO will take place in Chicago from 31 May to 3 June, 2014. The Annual Meeting brings together more than 25,000 oncology professionals from a broad range of clinical research specialties.
The NBTXR3 study was selected from over 5,500 abstracts received by the Scientific Program Committee of ASCO for review.
Laurent Levy, CEO of Nanobiotix said: We are honored that ASCO has invited us to present our NBTXR3 data in front of the international oncology community. This is an encouraging step for our team and our partners and we will continue to develop innovative therapies aimed to improve patient care in the fight against cancer.
About NANOBIOTIX - http://www.nanobiotix.com
Nanobiotix (Euronext: NANO / ISIN: FR0011341205) is a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer. The Companys first-in-class, proprietary technology, NanoXray, enhances radiotherapy energy to provide a new, more efficient treatment for cancer patients. NanoXray products are compatible with current radiotherapy treatments and are meant to treat a wide variety of cancers via multiple routes of administration.
Nanobiotixs lead product NBTXR3, based on NanoXray, is currently under clinical development for soft tissue sarcoma and locally advanced head and neck cancer. The Company, based in Paris, France, has partnered with PharmaEngine for clinical development and commercialization of NBTXR3 in Asia.
Nanobiotix is listed on the regulated market of NYSE Euronext in Paris (ISIN: FR0011341205, Euronext ticker: NANO, Bloomberg: NANO: FP).
Go here to read the rest:
Nanomedicine Book Site
1996-2013 Robert A. Freitas Jr. All Rights Reserved
Nanomedicine, Volume IIA: Biocompatibility by Robert A. Freitas Jr. is now available in hardcover for $99 + shipping. Click here to purchase the book at Amazon.com or click here for information or to purchase the book directly from Landes Bioscience.
Nanomedicine, Volume I: Basic Capabilities by Robert A. Freitas Jr. is now available in softcover for $89 + shipping. Click here for information or to purchase the book directly from Landes Bioscience.
About Nanomedicine (the field)
Molecular nanotechnology has been defined as the three-dimensional positional control of molecular structure to create materials and devices to molecular precision. The human body is comprised of molecules, hence the availability of molecular nanotechnology will permit dramatic progress in human medical services. More than just an extension of "molecular medicine," nanomedicine will employ molecular machine systems to address medical problems, and will use molecular knowledge to maintain and improve human health at the molecular scale. Nanomedicine will have extraordinary and far-reaching implications for the medical profession, for the definition of disease, for the diagnosis and treatment of medical conditions including aging, and ultimately for the improvement and extension of natural human biological structure and function.
Read more here:
Panel - The Regulation Environment in Nanomedicine -- The Step to the Last Phase of Translation
Participants: -Dr. Falk Ehmann, Scientific Support and Projects, European Medicines Agency, London (UK) -Dr. Kumiko Sakai-Kato, National Institute of Health ...
By: TAUVOD
Read the original here:
Looking and Listening to Light from Liposome Nanostructures for Cancer Theranostics
Chair Prof. Dr. Jan Mollenhauer, NanoCAN, University of Southern Denmark, (DK) Speaker: Prof. Dr. Kostas Kostarelos, FRSM, FIoN, FRSA, Chair of Nanomedicine,...
By: TAUVOD
Read the original:
Looking and Listening to Light from Liposome Nanostructures for Cancer Theranostics - Video